Management of Ocular Graft-Versus-Host Disease: A Brief Review
نویسندگان
doi
10.22037/joos.v3i4.36398چکیده
Graft-versus-host disease (GVHD) remains a major complication following hematopoietic stem cell transplantation (HSCT). Ocular GVHD develops in a substantial number of patients following HSCT and 60 % to 90 % of patients with systemic GVHD experience the ocular complications to some extents. In this brief review we will discuss the conventional and updated novel therapies in the management of patients suffering from ocular GVHD. Keywords: Eye; Dry Eye; Graft versus Host Disease; Treatment.